- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
'Injectible tan' leads to rapidly changing moles, experts say
Author(s):
Dublin, Ireland - Melanotan, an unlicensed medicine that works by increasing the levels of melanin in a person's body after being injected, has been linked to rapidly changing moles, the Evening Herald reports.
Dublin, Ireland
- Melanotan, an unlicensed drug that works by increasing the levels of melanin in a person’s body after injection, has been linked to rapidly changing moles, the
Evening Herald
reports.
The United Kingdom’s Medicines and Healthcare products Regulatory Agency has warned consumers to avoid the product because it has not been tested for safety, quality or effectiveness and its side effects are unknown, according to the
Herald
.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
